Litigation Details for ASTRAZENECA AB v. TORRENT PHARMA INC. (D.N.J. 2015)
✉ Email this page to a colleague
ASTRAZENECA AB v. TORRENT PHARMA INC. (D.N.J. 2015)
| Docket | 3:15-cv-03375 | Date Filed | 2015-05-15 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-06-13 |
| Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
| Jury Demand | None | Referred To | Douglas Arpert |
| Parties | APOTEX CORP. | ||
| Patents | 8,431,154; 8,536,206; 8,604,064; 8,618,142 | ||
| Attorneys | APOTEX CORP. | ||
| Firms | Fleming Ruvoldt PLLC; Ravin R. Patel | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASTRAZENECA AB v. TORRENT PHARMA INC.
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Details for ASTRAZENECA AB v. TORRENT PHARMA INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-05-15 | External link to document | |||
| 2015-05-15 | 106 | Order | term "roflumilast" as it appears in U.S. Patent Nos. 8,536,206, 8,604,064, and 8,618,142, means "N-(3,5…2015 13 June 2018 3:15-cv-03375 830 Patent None District Court, D. New Jersey | External link to document |
| 2015-05-15 | 134 | Opinion | three of the patents involved in this action: U.S. Patent Nos. 8,536,206 (the “‘206 Patent”), 8,604,064…roflumilast. ‘206 Patent at 1:1-17; ‘064 Patent at 1:1-19; ‘142 Patent at 1:1-19; ‘791 Patent at 8:29-20:…roflumilast. ‘206 Patent at 1:4-9; ‘064 Patent at 1:4-13; ‘142 Patent at 1:4-13; ‘791 Patent at 8:29-20:6… ‘791 Patent on November 26, 2008. 206 Patent at 1:4-9; ‘064 Patent at 1:4-13; ‘142 Patent at 1:4-13…8,604,064 (the “‘064 Patent”), and 8,618,142 (the “‘142 Patent”) (collectively, the “Patents-at-Issue”). The | External link to document |
| 2015-05-15 | 181 | Opinion | difluoromethoxybenzamide” in U.S. Patent Nos. 8,536,206 (the “‘206 Patent”), 8,604,064 (the “‘064 Patent”), and 8,618,142…roflumilast. ‘206 Patent at 1:1-17; ‘064 Patent at 1:1-19; ‘142 Patent at 1:1-19; ‘791 Patent at 8:29-20:6…206 Patent at 8:21-10:34; ‘064 Patent at 8:37-10:33; ‘142 Patent at 8:22-9:21. 3 The ‘791 Patent, not…the same family of patents as U.S. Patent No. 7,470,791 (the “‘791 Patent”), which purportedly protects…:6. Both the ‘206 Patent and the ‘064 Patent are process patents that claim methods for the treatment | External link to document |
| 2015-05-15 | 231 | Order | Licensed Patents” shall mean United States Patent Numbers 8,604,064, 8,618,142 and 8,536,206; and (…assigns, is enjoined from infringing the Licensed Patents, on its own part or through any Affiliate, …2015 13 June 2018 3:15-cv-03375 830 Patent None District Court, D. New Jersey | External link to document |
| 2015-05-15 | 53 | Stipulation and Order | STIPULATION AND CONSENT ORDER re: 8,431,154 patent; the current 3/1/2016 deadline for Takeda and…2015 13 June 2018 3:15-cv-03375 830 Patent None District Court, D. New Jersey | External link to document |
| 2015-05-15 | 54 | Stipulation and Order | STIPULATION AND CONSENT ORDER re: 8,431,154 patent; the current 2/29/2016 deadline for Citron and…2015 13 June 2018 3:15-cv-03375 830 Patent None District Court, D. New Jersey | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
